KNDS IPO: Record Orders, State Vetoes, and a €500m US Artillery Prize Frame July's Float
26.06.2026 - 03:43:50 | boerse-global.de
The Franco-German tank maker KNDS is poised to test investor appetite next month with a dual listing in Paris and Frankfurt, but the real heat could come from a single US Army decision. The company and its joint-venture partner Leonardo DRS are competing for a massive artillery programme covering 500 systems, with a verdict expected to coincide with the IPO window. Winning that contract would be a potent demand driver among the institutional buyers who alone will have access to the shares.
The offering marks the culmination of years of geopolitical rearmament, yet the pricing has been dialed back sharply. Where owners once hoped for a valuation of around $23bn, the banking syndicate led by Goldman Sachs, BofA Securities, Deutsche Bank and Société Générale now sees a range of €15bn to €18bn. The discount reflects a unique governance structure that places near-total control in the hands of the French and German states for the next decade.
Sellers are limiting the free float to a maximum of 20% of existing shares. Retail investors are locked out; only institutional funds can participate. On one side, the French state holding GIAT Industries is divesting holdings; on the other, the German private holding Wegmann & Co. is reducing its stake. Meanwhile, Germany plans to acquire a 40% interest via KfW, the state development bank, subject to approval from the Bundestag’s budget committee. A ten-year lock-up clause prevents either anchor from letting its stake dip below 30% without the other’s consent. The future supervisory board will seat twelve members, three from each government, each holding a veto over strategic moves.
Operationally, the numbers are imposing. The order backlog stood at €33.1bn at the end of 2025, giving a book-to-bill ratio of 3.1 — every euro of revenue was covered three times over by new contracts. Last year’s sales hit €4.4bn, while EBIT came in at €661m and free cash flow reached €980m. Management expects around 30% revenue growth in 2026, though the operating margin is set to ease to roughly 12% as large domestic programmes ramp up and some highly profitable legacy orders are completed. Medium-term targets call for annual sales of €11bn to €12bn and an EBIT margin of 14–15%.
Should investors sell immediately? Or is it worth buying KNDS?
The investment bill is heavy: capital expenditures on property and equipment alone are planned at €750m this year, and free cash flow is forecast to drop to just over €250m. Over the medium horizon, the group aims for cumulative free cash flow of €2.5bn to €3.0bn.
To sweeten the deal for long-term shareholders, KNDS is promising a generous payout. From the 2026 financial year, 40% of net profit will go to investors, with the first distribution in 2027. A loyalty programme grants double voting rights to anyone who holds and registers shares for two consecutive years, though a cap ensures GIAT and KfW remain equal in voting power as long as each holds at least 30%.
Market conditions are testing, however. European defence stocks have corrected sharply after a multi-year bull run. Rheinmetall, the group’s direct German rival, has already lost a quarter of its market value this year. Reports emerged that the Düsseldorf-based company had sought to buy into KNDS, but the two governments blocked the move.
KNDS at a turning point? This analysis reveals what investors need to know now.
All eyes now turn to the US Army’s artillery decision in July. A win for the KNDS-Leonardo DRS consortium would not only fill the order book further but also provide a powerful narrative for institutional investors asked to look past the state-imposed constraints on control and liquidity. UBS is acting as senior bookrunner alongside the four coordinator banks, with the listing expected within weeks.
Ad
KNDS Stock: New Analysis - 26 June
Fresh KNDS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
